Screening for pancreatic lipase inhibitors: evaluating assay conditions using p-nitrophenyl palmitate as substrate

Current in vitro pancreatic lipase inhibitor screenings are based on previous spectrophotometric lipase assays. Nevertheless, they are with little evaluation of assay conditions. This study focuses on the impacts of experimental factors on enzyme activity in the assay with p-nitrophenyl palmitate as...

Full description

Bibliographic Details
Main Authors: Cam-Van T. Vo, Nhan V. H. Luu, Thoai T. H. Nguyen, Truc T. Nguyen, Bach Q. Ho, Thuong H. Nguyen, Thanh-Dao Tran, Quoc-Thai Nguyen
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:All Life
Subjects:
Online Access:http://dx.doi.org/10.1080/26895293.2021.2019131
_version_ 1797236929578663936
author Cam-Van T. Vo
Nhan V. H. Luu
Thoai T. H. Nguyen
Truc T. Nguyen
Bach Q. Ho
Thuong H. Nguyen
Thanh-Dao Tran
Quoc-Thai Nguyen
author_facet Cam-Van T. Vo
Nhan V. H. Luu
Thoai T. H. Nguyen
Truc T. Nguyen
Bach Q. Ho
Thuong H. Nguyen
Thanh-Dao Tran
Quoc-Thai Nguyen
author_sort Cam-Van T. Vo
collection DOAJ
description Current in vitro pancreatic lipase inhibitor screenings are based on previous spectrophotometric lipase assays. Nevertheless, they are with little evaluation of assay conditions. This study focuses on the impacts of experimental factors on enzyme activity in the assay with p-nitrophenyl palmitate as substrate by monitoring their effects on the hydrolysis rates. On the results, experimental conditions for lipase inhibitory assay were proposed. Notably, 5 mM sodium deoxycholate as emulsifier not only maintains the assay homogeneity but also enhances lipase activity. Organic co-solvents to dissolve organic inhibitors including DMSO, EtOH, MeOH, IPA, AcCN [0–30% (v/v)] was found well tolerated by the enzyme. With 10% (v/v) glycerol, lipase solutions can be stored at –20°C for up to one month without significant loss of activity. The results reported here provide researchers the assay condition sets in which most inhibitors can be dissolved, and lipase activity is not severely affected. This could accelerate the rational development of novel lipase inhibitors.
first_indexed 2024-03-08T16:58:52Z
format Article
id doaj.art-6c0e7390ffdd4895909f9967a699dc7d
institution Directory Open Access Journal
issn 2689-5307
language English
last_indexed 2024-04-24T17:11:40Z
publishDate 2022-12-01
publisher Taylor & Francis Group
record_format Article
series All Life
spelling doaj.art-6c0e7390ffdd4895909f9967a699dc7d2024-03-28T09:48:50ZengTaylor & Francis GroupAll Life2689-53072022-12-01151132210.1080/26895293.2021.20191312019131Screening for pancreatic lipase inhibitors: evaluating assay conditions using p-nitrophenyl palmitate as substrateCam-Van T. Vo0Nhan V. H. Luu1Thoai T. H. Nguyen2Truc T. Nguyen3Bach Q. Ho4Thuong H. Nguyen5Thanh-Dao Tran6Quoc-Thai Nguyen7University of Medicine and Pharmacy at Ho Chi Minh CityUniversity of Medicine and Pharmacy at Ho Chi Minh CityUniversity of Medicine and Pharmacy at Ho Chi Minh CityUniversity of Medicine and Pharmacy at Ho Chi Minh CityUniversity of Medicine and Pharmacy at Ho Chi Minh CityUniversity of Medicine and Pharmacy at Ho Chi Minh CityUniversity of Medicine and Pharmacy at Ho Chi Minh CityUniversity of Medicine and Pharmacy at Ho Chi Minh CityCurrent in vitro pancreatic lipase inhibitor screenings are based on previous spectrophotometric lipase assays. Nevertheless, they are with little evaluation of assay conditions. This study focuses on the impacts of experimental factors on enzyme activity in the assay with p-nitrophenyl palmitate as substrate by monitoring their effects on the hydrolysis rates. On the results, experimental conditions for lipase inhibitory assay were proposed. Notably, 5 mM sodium deoxycholate as emulsifier not only maintains the assay homogeneity but also enhances lipase activity. Organic co-solvents to dissolve organic inhibitors including DMSO, EtOH, MeOH, IPA, AcCN [0–30% (v/v)] was found well tolerated by the enzyme. With 10% (v/v) glycerol, lipase solutions can be stored at –20°C for up to one month without significant loss of activity. The results reported here provide researchers the assay condition sets in which most inhibitors can be dissolved, and lipase activity is not severely affected. This could accelerate the rational development of novel lipase inhibitors.http://dx.doi.org/10.1080/26895293.2021.2019131lipase assaypancreatic lipase inhibitorsp-nitrophenyl esters
spellingShingle Cam-Van T. Vo
Nhan V. H. Luu
Thoai T. H. Nguyen
Truc T. Nguyen
Bach Q. Ho
Thuong H. Nguyen
Thanh-Dao Tran
Quoc-Thai Nguyen
Screening for pancreatic lipase inhibitors: evaluating assay conditions using p-nitrophenyl palmitate as substrate
All Life
lipase assay
pancreatic lipase inhibitors
p-nitrophenyl esters
title Screening for pancreatic lipase inhibitors: evaluating assay conditions using p-nitrophenyl palmitate as substrate
title_full Screening for pancreatic lipase inhibitors: evaluating assay conditions using p-nitrophenyl palmitate as substrate
title_fullStr Screening for pancreatic lipase inhibitors: evaluating assay conditions using p-nitrophenyl palmitate as substrate
title_full_unstemmed Screening for pancreatic lipase inhibitors: evaluating assay conditions using p-nitrophenyl palmitate as substrate
title_short Screening for pancreatic lipase inhibitors: evaluating assay conditions using p-nitrophenyl palmitate as substrate
title_sort screening for pancreatic lipase inhibitors evaluating assay conditions using p nitrophenyl palmitate as substrate
topic lipase assay
pancreatic lipase inhibitors
p-nitrophenyl esters
url http://dx.doi.org/10.1080/26895293.2021.2019131
work_keys_str_mv AT camvantvo screeningforpancreaticlipaseinhibitorsevaluatingassayconditionsusingpnitrophenylpalmitateassubstrate
AT nhanvhluu screeningforpancreaticlipaseinhibitorsevaluatingassayconditionsusingpnitrophenylpalmitateassubstrate
AT thoaithnguyen screeningforpancreaticlipaseinhibitorsevaluatingassayconditionsusingpnitrophenylpalmitateassubstrate
AT tructnguyen screeningforpancreaticlipaseinhibitorsevaluatingassayconditionsusingpnitrophenylpalmitateassubstrate
AT bachqho screeningforpancreaticlipaseinhibitorsevaluatingassayconditionsusingpnitrophenylpalmitateassubstrate
AT thuonghnguyen screeningforpancreaticlipaseinhibitorsevaluatingassayconditionsusingpnitrophenylpalmitateassubstrate
AT thanhdaotran screeningforpancreaticlipaseinhibitorsevaluatingassayconditionsusingpnitrophenylpalmitateassubstrate
AT quocthainguyen screeningforpancreaticlipaseinhibitorsevaluatingassayconditionsusingpnitrophenylpalmitateassubstrate